Article

DSAEK graft effect on refractive power holds implications for cataract surgery patients

A study from Duke University Eye Center showing that Descemet?s stripping automated endothelial keratoplasty (DSAEK) grafts add refractive power to the posterior surface of the cornea has implications for graft patients undergoing cataract surgery.

A study from Duke University Eye Center showing that Descemet's stripping automated endothelialkeratoplasty (DSAEK) grafts add refractive power to the posterior surface of the cornea hasimplications for graft patients undergoing cataract surgery.

"Further studies are warranted to understand the mechanism of the refractive change associatedwith the DSAEK graft," said Bokkwan Jun, MD, research associate, Duke University, Durham, NC."However, we recommend considering adjusting the IOL power in patients undergoing a DSAEKtriple procedure (DSAEK, phacoemulsification, and IOL implantation) and in DSAEK patientsundergoing cataract surgery."

Dr. Jun and colleagues undertook a retrospective review of all cases of DSAEK surgery performedby three surgeons at the Duke University Eye Center between August 2005 and December 2006, inorder to investigate any postoperative refractive change and correlations with graft thicknessand diameter. Data were analyzed for a total of 45 cases of 44 patients that had at least 3months follow-up after DSAEK and refractive data preoperatively and at last follow-up.

The overall refractive change in the 45 eyes was +0.88 D. After subgroup classification, themean refractive change was +1.15 D in 17 eyes that underwent DSAEK triple surgery and +0.71 Din 28 pseudophakic DSAEK eyes. The difference between the two groups was not statisticallysignificant.

A negative correlation was found between the amount of refractive change and graft centralthickness, although it was not statistically significant. There was a positive correlationbetween the refractive change and graft diameter that approached statistical significance(p = 0.05).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.